1 year return (CAGR)
-47.66%
Metagenomi, Inc. Common Stock Exchange (NASDAQ, USD)
MGX
1.12
+0.02 (+1.82%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
42.31M
Price/Sales
3.12
Ent value
64.42M
Price/Book
0.38
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.11 |
| Daily high | 1.14 |
| Daily low | 1.09 |
| Daily Volume | 101K |
| All-time high | 12.25 |
| 1y analyst estimate | 7.00 |
| Beta | 0.67 |
| EPS (TTM) | -2.48 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| MGX | S&P500 | |
| Current price drop from All-time high | -90.86% | -0.56% |
| Highest price drop | -91.02% | -56.47% |
| Date of highest drop | 18 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -75.47% | -10.68% |
| Avg time to new high | 131 days | 12 days |
| Max time to new high | 652 days | 1805 days |
News
